Marinus Pharmaceuticals has completed enrollment for the Phase 2a clinical randomized, controlled trial of ganaxolone in adult uncontrolled partial-onset seizures at multiple sites around the U.S.

Please contact www.clinicaltrials.gov, keyword: MARINUS for more information. Consult with your physician to see if you are able to participate in the clinical trial or Marinus Pharmaceuticals can be reached at 203-315-5809 or clincaltrials@marinuspharma.com.